Clinical Practice Portfolio – Neurotransmitters Chart
An 889-word writing guides for MSN students for MSN coursework, formatted in APA 7 (about 4 double-spaced pages).
- Type
- Writing Guides for MSN students
- Level
- MSN
- Length
- 889 words, 4 pages
- Style
- APA 7
Writing Guides for MSN studentsMSNAPA 7
Clinical Practice Portfolio – Neurotransmitters Chart
| Psychiatric Mental Health Nurse Practitioner Clinical Practice Portfolio – Neurotransmitters Chart for NU670-8c- Advanced Psychopharmacology and Health Promotion | |||||||
| Psychiatric Mental Health Nurse Practitioner Clinical Practice Portfolio – Neurotransmitters Chart | Function (Excitatory or Inhibitory) | Locations | Receptors | Effects of Deficient | Effects of Surplus | Agonist Drug | Antagonist Drug |
| Acetylcholine | Excitatory | Several different locations of the brain including striatal complex, the basal forebrain and the medulla | Acetylcholine receptors either nicotinic and muscarinic subunits | Memory impairment and brain disorders | Having excess acetylcholine accumulated at the synapses and neuromuscular junctions triggers symptoms of muscarinic and nicotinic toxicity. These symptoms include cramps, lacrimation, and blurry vision amongst others. | Include nicotine, choline, epibatidine,obeline, varenicline and cysteine mimic the action of acetylcholine | Compete with actions of acetylcholine for example atropine competes for a common binding site on all muscarinic receptors |
| Dopamine | Both excitatory and inhibitory | Located in the mid brain at the substania nigra and ventra tegmental area. Also found in hypothalamus and arcuate nucleus | There are five types of dopamine receptors with each having a specific function or functions. They are D1, D2, D3, D4, and D5. The functions of D1 include memory, attention, locomotion, regulation of renal function and impulse control. | Aches and pains, tremors, spasms, tremors, muscle cramps and muscle stiffness | One becomes aggressive, competitive, and have poor impulse control. It can lead to gambling, addiction, binge eating and ADHD. | Include Bromocriptine, cabergoline, Rotigitine and Apomorphine. | Clozepine, Chlorpromazine, promethazine and risperidone. |
| Endorphins | Inhibitory | Are released from the pituitary gland in response to pain and can act in both the central nervous system and the peripheral nervous system. | Bind with μ-receptors of peripheral nerves thus inhibiting the transmission of pain signals | Leads to depression and headaches | Besides decreased feelings of pain, secretion of endorphins leads to feelings of euphoria, modulation of appetite, release of sex hormones, and enhancement of the immune response. | .methadone and buprenorphine intramuscular heroin | Naloxone and naltrexone used in opioid antagonists drugs and as competitive antagonists bind to the opioid receptors without activating the receptors. |
| GABA | inhibitory | The Limbic system where personal feelings and emotional memories are generated and stored. | There are two classes of GABA receptors namely ionotropic receptors( GABAA) and metabotropic receptors(GABAB | Lower than normal levels of GABA in the brain is associate with sleep disorders, anxiety. Depression and schizophrenia | Causes hypersomnia or daytime sleepiness. | GABA (a) receptor agonists are like alcohol, barbiturates and benzodiazepine. GABA(b) receptor agonists include propofol, sodium oxybate and Baclofen. GABA analogs are like gabapentin, pregabalin and Valproic acid | Include bicuculline, securinine and metrazol Conventionally, these drugs generate a stimulant and convulsant effects hence their use to counter overdose of sedative drugs. |
| Glutamate | Excitatory | Occurs in protein- containing foods like cheese milk and mushrooms but is also produced by the human body.in the CNS | Glutamate receptors are found on the dendrites of postsynaptic cells and bind with glutamate released in into the synaptic cleft by presynaptic cells | Causes insomnia, mental exhaustion and difficulties in concentration. | Increase cellular activity, leading to over excitation on nerve cells which eventually causes cell death. | Cycloutylene AP5 and DCG IV Kainic acid and Quisqualic acid | Amantadine, |
| Glycine | inhibitory | In the brain stem and spinal cord. | Glycine receptors have the function of fast inhibitory transmission in the CNS. Suppress neural firing through hyper polarization that occurs when glycine activates anion channels. | Means the body produces less glutathione that negatively impacts on how one body handles oxidative stress over time. | Elevated glycine levels within the brain and cerebrospinal fluid cause’s seizures, breathing difficulties, movement disorders and intellectual disability. | D- Alanine L- Serine | Can either be selective like Brucine, Tutin and Strychnine or non-selective like Pitrazepin, Caffeine, Pictrotoxin and Bicuculine |
| Glutamate | excitatory | Occurs in protein- containing foods like cheese milk and mushrooms but is also produced by the human body.in the CNS | Glutamate receptors are found on the dendrites of postsynaptic cells and bind with glutamate released in into the synaptic cleft by presynaptic cells | Causes insomnia, mental exhaustion and difficulties in concentration. | Increase cellular activity, leading to over excitation on nerve cells which eventually causes cell death. | Cycloutylene AP5 and DCG IV Kainic acid and Quisqualic acid | Amantadine, |
| Norepinephrine | Excitatory | Produced in the inner part of the adrenal glands called the adrenal medulla | Norepinephrine binds to alpha- and beta-adrenergic receptors or adrenoceptors in different tissues. For example in the blood vessels it triggers vasoconstrictive thus increasing blood pressure. | Low levels of Norepinephrine is associated with ADHD, lack of concentration, lethargy and even depression. | Can lead to panic attacks, elevated blood pressure, euphoria ,and general hyperactivity | Epinephrine | Tricyclic antidepressant, beta blockers and antipsychotics |
| Serotonin | inhibitory | Primarily found in the enteric nervous system whose location is within the gastrointestinal tract though its production occurs in the CNS. | Serotonin membrane depolarization occurs after fast mediation and excitatory responses by 5-HT3 receptors located on neurons in both PNS and CNS. | Serotonin Levels below normal are associated with depression, anxiety and sleep | Excessive levels of Serotonin causes mild shivering and diarrhea to severe muscle rigidity , fever, and seizures | Serotonin 5-HT-Receptor Agonists Addyi.almotriptan.Amerge.Axert.eletriptan.flibanserin.Frova.frovatriptan. | 5-HT3 antagonists include Dolasetron. Granisetron. Ondansetron. Palonosetron. |
Notes: Clinical Practice Portfolio – Neurotransmitters Chart from the NU670-8c- Advanced Psychopharmacology and Health Promotion class

Commonly Used Drugs and Treatment Information Charts:
https://www.drugabuse.gov/sites/default/files/nida_commonlyuseddrugs_final_printready.pdf
Withdrawal Sx Chart
This paper is a sample from a completed student assignment, published to help you understand structure, argument and APA formatting. Use it for inspiration and reference only, and cite it if you quote it.
Get this paper as a Word file
clinical-practice-portfolio-neurotransmitters-ch.docx, with an APA title page and reference list, ready to edit in Word or Google Docs.
Need a custom paper on Clinical Practice Portfolio – Neurotransmitters Chart?
Get an original, plagiarism-free paper written to your rubric by a nursing expert.
Cite This Paper
Pick your style, then copy. Italics are kept when you paste into Word or Google Docs.
MSNStudy. (2024, November 13). Clinical Practice Portfolio – Neurotransmitters Chart [Writing guides for MSN students example]. https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/
(MSNStudy, 2024)
MSNStudy. (2024, November 13). Clinical Practice Portfolio – Neurotransmitters Chart [Writing guides for MSN students example]. Retrieved from https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/
(MSNStudy, 2024)
“Clinical Practice Portfolio – Neurotransmitters Chart.” MSNStudy, 13 Nov. 2024, msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart.
(“Clinical Practice Portfolio –”)
MSNStudy (2024) Clinical Practice Portfolio – Neurotransmitters Chart. Available at: https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/ (Accessed: 15 October 2026).
(MSNStudy, 2024)
MSNStudy. 2024. “Clinical Practice Portfolio – Neurotransmitters Chart.” November 13, 2024. https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/.
(MSNStudy 2024)
MSNStudy. “Clinical Practice Portfolio – Neurotransmitters Chart.” November 13, 2024. https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/.
1. MSNStudy, “Clinical Practice Portfolio – Neurotransmitters Chart,” November 13, 2024, https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/.
MSNStudy. Clinical Practice Portfolio – Neurotransmitters Chart [Internet]. 2024 Nov 13 [cited 2026 Oct 15]. Available from: https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/
[1] or (1)
MSNStudy. Clinical Practice Portfolio – Neurotransmitters Chart. Published November 13, 2024. Accessed October 15, 2026. https://msnstudy.com/clinical-practice-portfolio-neurotransmitters-chart/
1
Published . Updated .







